510(k) Report

510(k) · Cleared

Cleared

VersaPAP Positive Airway Pressure (PAP) Device

K173918510(k) TraditionalCleared Aug 17, 2018238-day reviewClass II21 CFR 868.5690

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Trudell Medical International · BWF Spirometer, Therapeutic (Incentive)

Cleared on Aug 17, 2018 as substantially equivalent to K991300 (Dhd Healthcare Corp., 1999) after a 238-day review. Its family tree reaches back 2 generations to 1995. 1 later device descends from it.

Decided
Aug 17, 2018
Review
238 days
Class
Class II
Product code
BWF
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K944900 (1995). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 1 descendant K991300 · Boeing, Positive Airway Pressure (Pap) Therapy Device · Dhd Healthcare Corp. · 1999K944900 · Therapep · Dhd Diemolding Healthcare Div. · 19950
  1. Root · 2 generations backK944900 TherapepDhd Diemolding Healthcare Div. · 1995
  2. 1 generation backK991300 Boeing, Positive Airway Pressure (Pap) Therapy DeviceDhd Healthcare Corp. · 1999
  3. This deviceK173918 VersaPAP Positive Airway Pressure (PAP) DeviceTrudell Medical International · 2018
  4. Descendant · cites it directly · 0 of its ownK183108 Combined Aerobika OPEP and VersaPAP deviceTrudell Medical International · 2019

Most influential descendants

Showing 1 of 1 · See all
  • K183108Combined Aerobika OPEP and VersaPAP deviceTrudell Medical International · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K944900TherapepDhd Diemolding Healthcare Div.1995—
−1K991300Boeing, Positive Airway Pressure (Pap) Therapy DeviceDhd Healthcare Corp.1999—
0 (this device)K173918VersaPAP Positive Airway Pressure (PAP) DeviceTrudell Medical International2018—
+1K183108Combined Aerobika OPEP and VersaPAP deviceTrudell Medical International2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
FIG. 1 — Lineage of K173918, 1995–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in BWF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BWF device

  1. #1 K241152 InSeescore 9.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K991300Boeing, Positive Airway Pressure (Pap) Therapy Device
Summary page 4
…Regulatory Class II Product Code: BWF 3. Predicate Device Boeing, Positive Airway Pressure (PAP) Therapy Device, K991300 DHD Healthcare Corp DHD Healthcare Corp was purchased by Smith Medical. Smith Medical has changed the device name…
Dhd Healthcare Corp.1999—
†K173825MC 300R* NebulizerTrudell Medical International2018—
†K150173Aerobika OPEP Devive with ManometerTrudell Medical International2015—

Also cleared against K991300: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K183108Combined Aerobika OPEP and VersaPAP deviceTrudell Medical International20190

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 19.1 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K183108 (Trudell Medical International, 2019) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K991300.

How does its category compare?

All BWF devices

BWF Spirometer, Therapeutic (Incentive): FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · BWF

1in 2025

2007: 12009: 22010: 12013: 12014: 32015: 12016: 32017: 32018: 12019: 32020: 12021: 12022: 12023: 22024: 12025: 1
2007high 3 (2014) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BWF

281in 2019

2014: 105 days median2016: 149 days median2017: 136 days median2019: 281 days median
2007high 281 (2019) · low 105 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · BWF

1in 2020

2020: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BWF

3in 2025

2007: 12008: 22009: 32010: 52011: 392012: 52013: 192014: 52015: 162016: 62017: 72018: 72019: 162020: 52021: 92022: 82024: 112025: 3
2007high 39 (2011) · low 0 (2023)2025

MAUDE reports naming product code BWF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
20080—02
20092—03
20101—05
20110—039
20120—05
20131—019
2014310505
20151—016
2016314906
2017313607
20181—07
20193281016
20201—15
20211—09
20221—08
20232—00
20241—011
20251—03
20260—0—

What is it indicated for?

VersaPAP* is indicated for the treatment and prevention of atelectasis. VersaPAP* also has the ability to provide supplemental oxygen when used with compressed oxygen. The VersaPAP* device is for patients (ages 5 years and above) who are capable of following directions for Positive Airway Pressure Therapy in a hospital environment. The VersaPAP* device is a single patient, multiple use device intended to be used under the supervision of a healthcare professional.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K173918: VersaPAP Positive Airway Pressure (PAP) Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173918

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026